Not applicableUnknownNCT01560663
What this trial is testing
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
Who this might be right for
Breast CancerBreast Cancer Stage II-III
Miguel Martín Jiménez 415